IGKC and carcinoma: We identified the immunoglobulin kappa chain (IGKC), a B-cell immune gene gaining attention as a stromal biomarker predictive of prognosis in breast cancer and other carcinomas [20], as highly and differentially expressed within the sequencing results from our samples, decreasing in early neoplasias relative to normal tissue (Table S11 in Additional file 1).